These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

143 related items for PubMed ID: 2813417

  • 1. Replication of human immunodeficiency virus 1 and Moloney murine leukemia virus is inhibited by different heteroatom-containing analogs of myristic acid.
    Bryant ML, Heuckeroth RO, Kimata JT, Ratner L, Gordon JI.
    Proc Natl Acad Sci U S A; 1989 Nov; 86(22):8655-9. PubMed ID: 2813417
    [Abstract] [Full Text] [Related]

  • 2. Substrate specificity of Saccharomyces cerevisiae myristoyl-CoA: protein N-myristoyltransferase. Analysis of fatty acid analogs containing carbonyl groups, nitrogen heteroatoms, and nitrogen heterocycles in an in vitro enzyme assay and subsequent identification of inhibitors of human immunodeficiency virus I replication.
    Devadas B, Lu T, Katoh A, Kishore NS, Wade AC, Mehta PP, Rudnick DA, Bryant ML, Adams SP, Li Q.
    J Biol Chem; 1992 Apr 15; 267(11):7224-39. PubMed ID: 1559967
    [Abstract] [Full Text] [Related]

  • 3. Protein N-myristoylation in Escherichia coli: reconstitution of a eukaryotic protein modification in bacteria.
    Duronio RJ, Jackson-Machelski E, Heuckeroth RO, Olins PO, Devine CS, Yonemoto W, Slice LW, Taylor SS, Gordon JI.
    Proc Natl Acad Sci U S A; 1990 Feb 15; 87(4):1506-10. PubMed ID: 2406721
    [Abstract] [Full Text] [Related]

  • 4. Novel fatty acyl substrates for myristoyl-CoA:protein N-myristoyl-transferase.
    Heuckeroth RO, Jackson-Machelski E, Adams SP, Kishore NS, Huhn M, Katoh A, Lu T, Gokel GW, Gordon JI.
    J Lipid Res; 1990 Jun 15; 31(6):1121-9. PubMed ID: 2197361
    [Abstract] [Full Text] [Related]

  • 5. Incorporation of 12-methoxydodecanoate into the human immunodeficiency virus 1 gag polyprotein precursor inhibits its proteolytic processing and virus production in a chronically infected human lymphoid cell line.
    Bryant ML, Ratner L, Duronio RJ, Kishore NS, Devadas B, Adams SP, Gordon JI.
    Proc Natl Acad Sci U S A; 1991 Mar 15; 88(6):2055-9. PubMed ID: 2006142
    [Abstract] [Full Text] [Related]

  • 6. In vitro antiviral activities of myristic acid analogs against human immunodeficiency and hepatitis B viruses.
    Parang K, Wiebe LI, Knaus EE, Huang JS, Tyrrell DL, Csizmadia F.
    Antiviral Res; 1997 May 15; 34(3):75-90. PubMed ID: 9191015
    [Abstract] [Full Text] [Related]

  • 7. Altered membrane association of p60v-src and a murine 63-kDa N-myristoyl protein after incorporation of an oxygen-substituted analog of myristic acid.
    Heuckeroth RO, Gordon JI.
    Proc Natl Acad Sci U S A; 1989 Jul 15; 86(14):5262-6. PubMed ID: 2501783
    [Abstract] [Full Text] [Related]

  • 8. Functional analysis of protein N-myristoylation: metabolic labeling studies using three oxygen-substituted analogs of myristic acid and cultured mammalian cells provide evidence for protein-sequence-specific incorporation and analog-specific redistribution.
    Johnson DR, Cox AD, Solski PA, Devadas B, Adams SP, Leimgruber RM, Heuckeroth RO, Buss JE, Gordon JI.
    Proc Natl Acad Sci U S A; 1990 Nov 15; 87(21):8511-5. PubMed ID: 2236060
    [Abstract] [Full Text] [Related]

  • 9. The substrate specificity of Saccharomyces cerevisiae myristoyl-CoA:protein N-myristoyltransferase. Analysis of myristic acid analogs containing oxygen, sulfur, double bonds, triple bonds, and/or an aromatic residue.
    Kishore NS, Lu TB, Knoll LJ, Katoh A, Rudnick DA, Mehta PP, Devadas B, Huhn M, Atwood JL, Adams SP.
    J Biol Chem; 1991 May 15; 266(14):8835-55. PubMed ID: 2026598
    [Abstract] [Full Text] [Related]

  • 10. Metabolic activation of 2-substituted derivatives of myristic acid to form potent inhibitors of myristoyl CoA:protein N-myristoyltransferase.
    Paige LA, Zheng GQ, DeFrees SA, Cassady JM, Geahlen RL.
    Biochemistry; 1990 Nov 20; 29(46):10566-73. PubMed ID: 2271666
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Antiviral phospholipids. Anti-HIV drugs conjugated to the glycerobackbone of phospholipids.
    Pidgeon C, Markovich RJ, Liu MD, Holzer TJ, Novak RM, Keyer KA.
    J Biol Chem; 1993 Apr 15; 268(11):7773-8. PubMed ID: 7681828
    [Abstract] [Full Text] [Related]

  • 16. An analysis of the inhibition of replication of HIV and MuLV by some 3'-blocked pyrimidine analogs.
    Bazin H, Chattopadhyaya J, Datema R, Ericson AC, Gilljam G, Johansson NG, Hansen J, Koshida R, Moelling K, Oberg B.
    Biochem Pharmacol; 1989 Jan 01; 38(1):109-19. PubMed ID: 2462876
    [Abstract] [Full Text] [Related]

  • 17. Myristylation site in Pr65gag is essential for virus particle formation by Moloney murine leukemia virus.
    Rein A, McClure MR, Rice NR, Luftig RB, Schultz AM.
    Proc Natl Acad Sci U S A; 1986 Oct 01; 83(19):7246-50. PubMed ID: 3489936
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Myristic acid analogs are inhibitors of Junin virus replication.
    Cordo SM, Candurra NA, Damonte EB.
    Microbes Infect; 1999 Jul 01; 1(8):609-14. PubMed ID: 10611737
    [Abstract] [Full Text] [Related]

  • 20. Ebselen, a Small-Molecule Capsid Inhibitor of HIV-1 Replication.
    Thenin-Houssier S, de Vera IM, Pedro-Rosa L, Brady A, Richard A, Konnick B, Opp S, Buffone C, Fuhrmann J, Kota S, Billack B, Pietka-Ottlik M, Tellinghuisen T, Choe H, Spicer T, Scampavia L, Diaz-Griffero F, Kojetin DJ, Valente ST.
    Antimicrob Agents Chemother; 2016 Apr 01; 60(4):2195-208. PubMed ID: 26810656
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.